Clinical trials for Fabry disease
47 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT06906367A Study of Patients With Fabry Disease (US Specific)Amicus Therapeutics · PI: Clinical Research
- RECRUITINGPhase 3NCT06904261A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA VariantsAmicus Therapeutics
- RECRUITINGNCT07235709Effect of Agalsidase Alfa on Cardiac Inflammation in Patients With Fabry Disease: A [18F]-FDG PET-CMR StudyYonsei University
- RECRUITINGN/ANCT07187440A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry DiseaseTakeda · PI: Study Director
- ENROLLING BY INVITATIONN/ANCT07495410Anderson-Fabry Disease Fitness Improvement Training: A-FAD-FITGeneral University Hospital, Prague
- RECRUITINGPHASE2, PHASE3NCT06328608A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry DiseaseChiesi Farmaceutici S.p.A.
- RECRUITINGN/ANCT07382128Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy PhenotypesIRCCS Azienda Ospedaliero-Universitaria di Bologna · PI: Luigi Lovato
- RECRUITINGNCT06941025Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and BreastfeedingChiesi Farmaceutici S.p.A.
- RECRUITINGPhase 1NCT06858397A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry DiseaseGC Biopharma Corp · PI: GC Biopharma
- RECRUITINGN/ANCT06776419the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY DiseaseCaroline Michaela Kistorp · PI: Caroline Kistorp, Professor
- ENROLLING BY INVITATIONNCT06880250Efficacy and Safety of Enzyme Replacement Therapy in Patients With Fabry DiseaseNPO Petrovax · PI: Sergey V. Moiseev, MD
- RECRUITINGNCT04252066A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and BreastfeedingAmicus Therapeutics
- RECRUITINGNCT06884358Functional Capacity in Anderson-Fabry Disease PatientsIRCCS Policlinico S. Donato
- RECRUITINGNCT06663358A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry PatientsChiesi Farmaceutici S.p.A.
- RECRUITINGN/ANCT06539624Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry DiseaseThe Children's Hospital of Zhejiang University School of Medicine · PI: Jianhua Mao, PhD
- RECRUITINGN/ANCT07277361Study of the Quality of Life of Patients With Fabry Disease Aged 65 and Over With and Without Specific TreatmentWladimir MAUHIN, Dr · PI: Wladimir MAUHIN, Doctor
- RECRUITINGPhase 1NCT06270316Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry DiseaseUniQure Biopharma B.V. · PI: Arian Pano, MD, MPH
- RECRUITINGN/ANCT06325488Fibrosis, Inflammation, Oxygenation of Renal Tissue In FabrY DiseaseCaroline Michaela Kistorp · PI: Caroline M Kistorp, Professor
- RECRUITINGEarly Phase 1NCT06207552Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry DiseaseChildren's Hospital of Fudan University · PI: Hong Xu, MD,PhD
- RECRUITINGPhase 2NCT06114329Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry DiseaseAceLink Therapeutics, Inc. · PI: Nan Chen, Dr.
- ACTIVE NOT RECRUITINGN/ANCT06095713German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfaUniversität Münster · PI: Eva Brand, MD, PhD
- RECRUITINGN/ANCT05698901Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry DiseaseMackay Memorial Hospital · PI: Charles Jia-Yin Hou
- ACTIVE NOT RECRUITINGN/ANCT06052800Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in TaiwanSanofi · PI: Clinical Sciences and Operations
- RECRUITINGN/ANCT05923788T1 Mapping in Fabry DiseaseHospices Civils de Lyon · PI: SANDRINE LEMOINE, PU-PH
- RECRUITINGPHASE2, PHASE3NCT05710692Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry DiseaseChiesi Farmaceutici S.p.A.
- RECRUITINGNCT06610019Cardiovascular Multimodality Imaging StudyMontefiore Medical Center · PI: Leandro Slipczuk, MD, PhD
- RECRUITINGPhase 3NCT06081062Evaluate the Safety and Efficacy of Fabagal® (Agalsidase Beta) in Patients With Fabry DiseaseISU Abxis Co., Ltd.
- RECRUITINGPhase 4NCT05067868A Study of Replagal in Children and Adults With Fabry Disease in IndiaShire · PI: Study Director
- ACTIVE NOT RECRUITINGPhase 3NCT04020055A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal DiseaseAmicus Therapeutics · PI: Clinical Research
- ACTIVE NOT RECRUITINGNCT07506083Natural History in Fabry Disease With IVS4+919G>A MutationsChinese University of Hong Kong · PI: Alex PW Lee, Professor
- RECRUITINGPHASE1, PHASE2NCT056295594D-310 in Adults With Fabry Disease and Cardiac Involvement4D Molecular Therapeutics · PI: Alan H Cohen, MD
- ACTIVE NOT RECRUITINGPhase 3NCT05280548A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseSanofi · PI: Clinical Sciences & Operations Clinical Sciences and Operations
- ACTIVE NOT RECRUITINGPhase 3NCT05206773A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry DiseaseSanofi · PI: Clinical Sciences & Operations
- RECRUITINGN/ANCT06806813Italian Anderson Fabry Disease Cardiovascular RegistryIRCCS Azienda Ospedaliero-Universitaria di Bologna · PI: Elena Biagini, MD, PhD
- ENROLLING BY INVITATIONNCT05039866Long-Term Follow-up of Subjects Who Were Treated With ST-920Sangamo Therapeutics · PI: Medical Monitor
- ACTIVE NOT RECRUITINGN/ANCT04943991Fabry Disease in High-risk Patients With Left Ventricular Hypertrophy: Prevalence and Implementation of a Clinical ScoreWuerzburg University Hospital
- RECRUITINGN/ANCT04856059Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRIUniversity Health Network, Toronto · PI: Kate Hanneman
- RECRUITINGN/ANCT04440254Long Duration Holter ECG in Fabry DiseaseInstitut National de la Santé Et de la Recherche Médicale, France · PI: Albert HAGEGE, Dr
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04519749An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease4D Molecular Therapeutics · PI: Alan H Cohen, MD
- RECRUITINGN/ANCT06758648Characterizing the Retinal Microvasculature in Patients with Fabry Disease: a Prospective Observational StudyTechnical University of Munich · PI: Roman Günthner, PD Dr.
- ACTIVE NOT RECRUITINGN/ANCT03305250Arrhythmia Burden, Risk of Sudden Cardiac Death and Stroke in Patients With Fabry DiseaseUniversity Hospital Birmingham NHS Foundation Trust · PI: Richard Steeds, MD
- ACTIVE NOT RECRUITINGPhase 3NCT03737214A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry DiseaseIdorsia Pharmaceuticals Ltd. · PI: Clinical Trials
- ACTIVE NOT RECRUITINGPhase 3NCT03614234Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease PatientsChiesi Farmaceutici S.p.A.
- RECRUITINGNCT01581424Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease StudyUniversity of Minnesota · PI: Chet Whitley, MD
- RECRUITINGNCT00455104Canadian Fabry Disease Initiative (CFDI) National RegistryCanadian Fabry Research Consortium · PI: Michael L West, MD
- RECRUITINGN/ANCT00196742Fabry Disease Registry & Pregnancy Sub-registryGenzyme, a Sanofi Company · PI: Study Director
- RECRUITINGNCT03362164Evaluation of HEArt invoLvement in Patients With FABRY DiseaseWuerzburg University Hospital · PI: Peter Nordbeck, MD, PhD